Age-related brain pathology in Octodon degu: Blood vessel, white matter and Alzheimer-like pathology

Neurobiology of Aging

Volumn 32, Issue 9, 2011, Pages 1651-1661

  van Groen, Thomas ^a,b   Kadish, Inga ^a,b   Popović, Natalija ^c   Popović, Miroljub ^c,d   Caballero Bleda, María ^c,d   Baño Otálora, Beatriz ^c   Vivanco, Pablo ^c   Rol, María Ángeles ^c   Madrid, Juan Antonio ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF MURCIA   (Spain)

^d UNIVERSITY OF MURCIA   (Spain)

Author keywords

Aging; Alzheimer's disease; Beta amyloid; Cerebral amyloid angiopathy; Hippocampus; Octodon degus; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR LIKE PROTEIN 1; AMYLOID PRECURSOR LIKE PROTEIN 2; AMYLOID PRECURSOR PROTEIN; MYELIN; TAU PROTEIN; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; HIPPOCAMPUS; NEUROPATHOLOGY; NONHUMAN; OCTODON DEGU; PRIORITY JOURNAL; RODENT; VASCULAR AMYLOIDOSIS; WHITE MATTER;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; NERVE FIBERS, MYELINATED; OCTODON;

EID: 79960116870     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.10.008     Document Type: Article

References (53)

1. Braak H., Braak E., Strothjohann M. Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci. Lett. 1994, 171:1-4.
2. Brown C., Donnelly T.M. Cataracts and reduced fertility in degus (Octodon degus). Contracts secondary to spontaneous diabetes mellitus. Lab. Anim. (NY) 2001, 30:25-26.
3. Colle M.-A., Hauw J.-J., Crespeau F., Uchihara T., Akiyama H., Checler F., Pageat P., Duykaerts C. Vascular and parenchymal Abeta deposition in the aging dog: correlation with behavior. Neurobiol. Aging 2000, 21:695-704.
4. Cork L.C., Powers R.E., Selkoe D.J., Davies P., Geyer J.J., Price D.L. Neurofibrillary tangles and senile plaques in aged bears. J. Neuropathol. Exp. Neurol. 1998, 47:629-641.
5. Cotman C.W., Anderson K.J. Synaptic plasticity and functional stabilization in the hippocampal formation: possible role in Alzheimer's disease. Adv. Neurol. 1988, 47:313-335.
6. Crawford D., Cowan S., Hyder S., McMenamin M., Smith D., Leake R. New storage procedure for human tumor biopsies prior to estrogen receptor measurement. Cancer Res. 1984, 44:2348-2351.
7. Czasch S., Paul S., Baumgärtner W.A. Comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol. Aging 2006, 27:293-305.
8. De Lacoste M.-C., White C.L. The role of cortical connectivity in Alzheiemr's disease pathogenesis: a review and model system. Neurobiol. Aging 1993, 14:1-16.
9. De Strooper B., Simons M., Multhaup G., Van Leuven F., Beyreuther K., Dotti C.G. Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J. 1995, 14:4932-4938.
10. Dickson T.C., Vickers J.C. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 2001, 105:99-107.
11. Franciosi S., De Gasperi R., Dickstein D.L., English D.F., Rocher A.B., Janssen W.G., Christoffel D., Sosa M.A., Hof P.R., Buxbaum J.D., Elder G.A. Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain. J. Neurosci. Methods 2007, 163:76-82.
12. Fulk G. Notes on the activity, reproduction, and social behavior of Octodon degus. J. Mammal. 1976, 57:495-505.
13. Galuppo S., Bacigalupo A., García A., Ortiz S., Coronado X., Cattan P.E., Solari A. Predominance of Trypanosoma cruzi genotypes in two reservoirs infected by sylvatic Triatoma infestans of an endemic area of Chile. Acta Trop. 2009, 111:90-93.
14. Galluzzi S., Lanni C., Pantoni L., Filippi M., Frisoni G.B. White matter lesions in the elderly: pathophysiological hypothesis on the effect on brain plasticity and reserve. J. Neurol. Sci. 2008, 273:3-9.
15. Gottfries C.G., Balldin J., Blennow K., Bråne G., Karlsson I., Regland B., Wallin A. Hypothalamic dysfunction in dementia. J. Neural. Transm. Suppl. 1994, 43:203-209.
16. Guénette S.Y., Tanzi R.E. Progress toward valid transgenic mouse models for Alzheimer's disease. Neurobiol. Aging 1999, 20:201-211.
17. Härtig W., Klein C., Brauer K., Schüppel K.F., Arendt T., Brückner G., Bigl V. Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders. Acta Neuropathol. 2000, 100:305-312.
18. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 2003, 60:1119-1122.
19. Helzner E.P., Luchsinger J.A., Scarmeas N., Cosentino S., Brickman A.M., Glymour M.M., Stern Y. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch. Neurol. 2009, 66:343-348.
20. Hirtz D., Thurman D.J., Gwinn-Hardy K., Mohamed M., Chaudhuri A.R., Zalutsky R. How common are the "common" neurologic disorders?. Neurology 2007, 68:326-337.
21. Honjo K., van Reekum R., Verhoeff N.P. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?. Alzheimers Dement. 2009, 5:348-360.
22. Hyman B.T., Trojanowski J.Q. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J. Neuropathol. Exp. Neurol. 1997, 56:1095-1097.
23. Ida N., Hartmann T., Pantel J., Schroder J., Zerfass R., Forstl H., Sandbrink R., Masters C.L., Beyreuther K. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J. Biol. Chem. 1996, 271:22908-22914.
24. Ikeda S.I., Allsop D., Glenner G.G. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. Lab. Invest. 1989, 60:113-122.
25. Inestrosa N.C., Reyes A.E., Chacón M.A., Cerpa W., Villalón A., Montiel J., Merabachvili G., Aldunate R., Bozinovic F., Aboitiz F. Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu. Neurobiol. Aging 2005, 26:1023-1028.
26. Itzhaki R.F., Wozniak M.A. Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J. Alzheimers Dis. 2008, 13:393-405.
27. Johnstone E.M., Chaney M.O., Norris F.H., Pascual R., Little S.P. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Mol. Brain Res. 1991, 10:299-305.
28. Kadish I., Thibault O., Blalock E.M., Chen K.C., Gant J.C., Porter N.M., Landfield P.W. Hippocampal and cognitive aging across the lifespan: a bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment. J. Neurosci. 2009, 29:1805-1816.
29. Kadish I., Pradier L., van Groen T. Transgenic mice expressing the human presenilin 1 gene demonstrate enhanced hippocampal reorganization following entorhinal cortex lesions. Brain Res. Bull. 2002, 57(5):587-594.
30. Lee T.M. Octodon degus: a diurnal, social, and long-lived rodent. ILAR J. 2004, 45:14-24.
31. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 2001, 24:1121-1159.
32. Lewejohann L., Reefmann N., Widmann P., Ambrée O., Herring A., Keyvani K., Paulus W., Sachser N. Transgenic Alzheimer mice in a semi-naturalistic environment: more plaques, yet not compromised in daily life. Behav. Brain Res. 2009, 201:99-102.
33. Morris J., Storandt M., McKeel D., Rubin E., Price J., Grant E., Berg L. Cerebral amyloid deposition and diffuse plaques in normal aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996, 46:707-719.
34. Ortiz V., Lozano J.P., Rol de Lama M.A., Madrid J.A. Rendimiento y deterioro cognitivo en Octodon degu, un nuevo modelo para ensayos conductuales. XLVII Congreso de la Sociedad Española de Geriatría y Gerontología 2005.
35. Popović N., Baño-Otálora B., Rol M.A., Caballero-Bleda M., Madrid J.A., Popović M. Aging and time-of-day effects on anxiety in female Octodon degus. Behav. Brain Res. 2009, 200:117-121.
36. Robinson S.R., Dobson C., Lyons J. Challenges and directions for the pathogen hypothesis of Alzheimer's disease. Neurobiol. Aging 2004, 25:629-637.
37. Rowe W.B., Blalock E.M., Chen K.C., Kadish I., Wang D., Barrett J.E., Thibault O., Porter N.M., Rose G.M., Landfield P.W. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J. Neurosci. 2007, 27:3098-3110.
38. Schmahmann J.D., Smith E.E., Eichler F.S., Filley C.M. Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann. N. Y. Acad. Sci. 2008, 1142:266-309.
39. Schmued L.C., Stowers C.C., Scallet A.C., Xu L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 2005, 1035:24-31.
40. Schmued L., Bowyer J., Cozart M., Heard D., Binienda Z., Paule M. Introducing Black-Gold II, a highly soluble gold phosphate complex with several unique advantages for the histochemical localization of myelin. Brain Res. 2008, 1229:210-217.
41. Selkoe D.J., Bell D.S., Podlisny M.B., Price D.L., Cork L.C. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 1987, 235:873-877.
42. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
43. Selkoe D.J., Wolfe M.S. Presenilin: running with scissors in the membrane. Cell 2007, 131:215-221.
44. Shepherd C., McCann H., Halliday G.M. Variations in the neuropathology of familial Alzheimer's disease. Acta Neuropathol. 2009, 118:37-52.
45. Sotiropoulos I., Cerqueira J.J., Catania C., Takashima A., Sousa N., Almeida O.F. Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. Neurosci. Biobehav. Rev. 2008, 32:1161-1173.
46. Spear G.S., Caple M.V., Sutherland L.R. The pancreas in the degu. Exp. Mol. Pathol. 1984, 40:295-310.
47. Stephenson D.T., Rash K., Clemens J.A. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 1992, 593:128-135.
48. Van Broeck B., Van Broeckhoven C., Kumar-Singh S. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches. Neurodegener. Dis. 2007, 4:349-365.
49. Van Groen T., Liu L., Ikonen S., Kadish I. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions. Neuroscience 2003, 119:1185-1197.
50. van Groen T., Kiliaan A.J., Kadish I. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. Neurobiol. Dis. 2006, 23:653-662.
51. Vivanco P., Ortiz V., Rol M.A., Madrid J.A. Looking for the keys to diurnality downstream from the circadian clock: role of melatonin in a dual-phasing rodent, Octodon degus. J. Pineal Res. 2007, 42:280-290.
52. Xu W., Qiu C., Gatz M., Pedersen N.L., Johansson B., Fratiglioni L. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 2009, 58:71-77.
53. Yoshiike Y., Chui D.H., Akagi T., Tanaka N., Takashima A. Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation. J. Biol. Chem. 2003, 278:23648-23655.